{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:32:05Z","timestamp":1785159125605,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["INST 336\/114-1 FUGG"],"award-info":[{"award-number":["INST 336\/114-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["SE2016\/7-3"],"award-info":[{"award-number":["SE2016\/7-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"crossref","award":["ReVAMP"],"award-info":[{"award-number":["ReVAMP"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"crossref","award":["V.A.Cure ITN"],"award-info":[{"award-number":["V.A.Cure ITN"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"crossref"}]},{"name":"French Tanguy Moyamoya Disease patients association"},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche Medicale","doi-asserted-by":"crossref","award":["DEQ20170336702"],"award-info":[{"award-number":["DEQ20170336702"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-17-CE13-022"],"award-info":[{"award-number":["ANR-17-CE13-022"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004238","name":"Universit\u00e4t Potsdam","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004238","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The capillary-venous pathology cerebral cavernous malformation (CCM) is caused by loss of CCM1\/Krev interaction trapped protein 1 (KRIT1), CCM2\/MGC4607, or CCM3\/PDCD10 in some endothelial cells. Mutations of <jats:italic>CCM<\/jats:italic> genes within the brain vasculature can lead to recurrent cerebral hemorrhages. Pharmacological treatment options are urgently needed when lesions are located in deeply-seated and in-operable regions of the central nervous system. Previous pharmacological suppression screens in disease models of CCM led to the discovery that treatment with retinoic acid improved CCM phenotypes. This finding raised a need to investigate the involvement of retinoic acid in CCM and test whether it has a curative effect in preclinical mouse models. Here, we show that components of the retinoic acid synthesis and degradation pathway are transcriptionally misregulated across disease models of CCM. We complemented this analysis by pharmacologically modifying retinoic acid levels in zebrafish and human endothelial cell models of CCM, and in acute and chronic mouse models of CCM. Our pharmacological intervention studies in CCM2-depleted human umbilical vein endothelial cells (HUVECs) and <jats:italic>krit1<\/jats:italic> mutant zebrafish showed positive effects when retinoic acid levels were increased. However, therapeutic approaches to prevent the development of vascular lesions in adult chronic murine models of CCM were drug regiment-sensitive, possibly due to adverse developmental effects of this hormone. A treatment with high doses of retinoic acid even worsened CCM lesions in an adult chronic murine model of CCM. This study provides evidence that retinoic acid signaling is impaired in the CCM pathophysiology and suggests that modification of retinoic acid levels can alleviate CCM phenotypes.<\/jats:p>","DOI":"10.1038\/s41598-023-31905-0","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T11:02:50Z","timestamp":1680692570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impaired retinoic acid signaling in cerebral cavernous malformations"],"prefix":"10.1038","volume":"13","author":[{"given":"Nastasja","family":"Grdseloff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenola","family":"Boulday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia J.","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Otten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphn\u00e9 Raphaelle","family":"Vannier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Faurobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Tournier-Lasserve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Abdelilah-Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"issue":"9","key":"31905_CR1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.molmed.2020.03.003","volume":"26","author":"S Abdelilah-Seyfried","year":"2020","unstructured":"Abdelilah-Seyfried, S., Tournier-Lasserve, E. & Derry, W. B. Blocking signalopathic events to treat cerebral cavernous malformations. Trends Mol. Med. 26(9), 874\u2013887 (2020).","journal-title":"Trends Mol. Med."},{"issue":"10","key":"31905_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201809155","volume":"10","author":"C Otten","year":"2018","unstructured":"Otten, C. et al. Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations. EMBO Mol. Med. 10(10), 1\u201317 (2018).","journal-title":"EMBO Mol. Med."},{"key":"31905_CR3","doi-asserted-by":"crossref","unstructured":"Niederreither, K., Subbarayan, V., Doll\u00e9, P., & Chambon, P. Embryonic Retinoic Acid Synthesis is Essential for Early Mouse Post-Implantation Development (1999).","DOI":"10.1038\/7788"},{"key":"31905_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1242\/dev.128.7.1019","volume":"128","author":"K Niederreither","year":"2001","unstructured":"Niederreither, K. et al. Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. Development 128, 1019\u20131031 (2001).","journal-title":"Development"},{"issue":"11","key":"31905_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1101\/gad.1184904","volume":"18","author":"BL Bohnsack","year":"2004","unstructured":"Bohnsack, B. L., Lai, L., Dolle, P. & Hirschi, K. K. Signaling hierarchy downstream of retinoic acid that independently regulates vascular remodeling and endothelial cell proliferation. Genes Dev. 18(11), 1345\u20131358 (2004).","journal-title":"Genes Dev."},{"issue":"26","key":"31905_CR6","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1242\/dev.00887","volume":"130","author":"L Lai","year":"2003","unstructured":"Lai, L., Bohnsack, B. L., Niederreither, K. & Hirschi, K. K. Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development 130(26), 6465\u20136474 (2003).","journal-title":"Development"},{"issue":"3","key":"31905_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/ENEURO.0378-16.2017","volume":"4","author":"S Bonney","year":"2017","unstructured":"Bonney, S. & Siegenthaler, J. A. Differential effects of retinoic acid concentrations in regulating blood\u2013brain barrier properties. eNeuro. 4(3), 1\u201314 (2017).","journal-title":"eNeuro."},{"issue":"4","key":"31905_CR8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1523\/JNEUROSCI.1338-12.2013","volume":"33","author":"MR Mizee","year":"2013","unstructured":"Mizee, M. R. et al. Retinoic acid induces blood\u2013brain barrier development. J. Neurosci. 33(4), 1660\u20131671 (2013).","journal-title":"J. Neurosci."},{"issue":"4","key":"31905_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0152105","volume":"11","author":"ME Katt","year":"2016","unstructured":"Katt, M. E., Xu, Z. S., Gerecht, S. & Searson, P. C. Human brain microvascular endothelial cells derived from the BC1 iPS cell line exhibit a blood\u2013brain barrier phenotype. PLoS ONE 11(4), 1\u201318 (2016).","journal-title":"PLoS ONE"},{"key":"31905_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep04160","volume":"4","author":"ES Lippmann","year":"2014","unstructured":"Lippmann, E. S., Al-Ahmad, A., Azarin, S. M., Palecek, S. P. & Shusta, E. V. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci. Rep. 4, 1\u201310 (2014).","journal-title":"Sci. Rep."},{"key":"31905_CR11","first-page":"93","volume":"101","author":"MJ Stebbins","year":"2016","unstructured":"Stebbins, M. J. et al. Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells Matthew. Physiol. Behav. 101, 93\u2013102 (2016).","journal-title":"Physiol. Behav."},{"key":"31905_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.phrs.2015.05.014","volume":"99","author":"L Kong","year":"2015","unstructured":"Kong, L. et al. Retinoic acid ameliorates blood\u2013brain barrier disruption following ischemic stroke in rats. Pharmacol. Res. 99, 125\u2013136 (2015).","journal-title":"Pharmacol. Res."},{"issue":"1","key":"31905_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7150\/ijbs.13229","volume":"12","author":"Y Zhou","year":"2016","unstructured":"Zhou, Y. et al. Retinoic acid induced-autophagic flux inhibits ER-stress dependent apoptosis and prevents disruption of blood\u2013spinal cord barrier after spinal cord injury. Int. J. Biol. Sci. 12(1), 87\u201399 (2016).","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"31905_CR14","doi-asserted-by":"publisher","first-page":"5674","DOI":"10.1096\/fj.201701469R","volume":"32","author":"LM Pollock","year":"2018","unstructured":"Pollock, L. M., Xie, J., Bell, B. A. & Anand-Apte, B. Retinoic acid signaling is essential for maintenance of the blood\u2013retinal barrier. FASEB J. 32(10), 5674\u20135684 (2018).","journal-title":"FASEB J."},{"issue":"3\u20134","key":"31905_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1242\/dmm.001263","volume":"2","author":"G Boulday","year":"2009","unstructured":"Boulday, G. et al. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: Implications for human cerebral cavernous malformations. DMM Dis. Models Mech. 2(3\u20134), 168\u2013177 (2009).","journal-title":"DMM Dis. Models Mech."},{"issue":"9","key":"31905_CR16","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.20110571","volume":"208","author":"G Boulday","year":"2011","unstructured":"Boulday, G. et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J. Exp. Med. 208(9), 1835\u20131847 (2011).","journal-title":"J. Exp. Med."},{"issue":"5","key":"31905_CR17","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1172\/JCI44393","volume":"121","author":"AC Chan","year":"2011","unstructured":"Chan, A. C. et al. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J. Clin. Investig. 121(5), 1871\u20131881 (2011).","journal-title":"J. Clin. Investig."},{"issue":"7455","key":"31905_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno, L. et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498(7455), 492\u2013496 (2013).","journal-title":"Nature"},{"issue":"27","key":"31905_CR19","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1073\/pnas.1501352112","volume":"112","author":"L Bravi","year":"2015","unstructured":"Bravi, L. et al. Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. Proc. Natl. Acad. Sci. USA 112(27), 8421\u20138426 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7597","key":"31905_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature17178","volume":"532","author":"Z Zhou","year":"2016","unstructured":"Zhou, Z. et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling. Nature 532(7597), 122\u2013126 (2016).","journal-title":"Nature"},{"issue":"10","key":"31905_CR21","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1161\/CIRCRESAHA.119.315076","volume":"125","author":"CJ R\u00f6del","year":"2019","unstructured":"R\u00f6del, C. J. et al. Blood flow suppresses vascular anomalies in a zebrafish model of cerebral cavernous malformations. Circ. Res. 125(10), e43\u2013e54 (2019).","journal-title":"Circ. Res."},{"key":"31905_CR22","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/STROKEAHA.119.027207","volume":"51","author":"C Cardoso","year":"2020","unstructured":"Cardoso, C. et al. Novel chronic mouse model of cerebral cavernous malformations. Stroke 51, 1272\u20131278 (2020).","journal-title":"Stroke"},{"issue":"4","key":"31905_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10456-020-09736-8","volume":"23","author":"MR Detter","year":"2020","unstructured":"Detter, M. R. et al. Novel murine models of cerebral cavernous malformations. Angiogenesis 23(4), 651\u2013666 (2020).","journal-title":"Angiogenesis"},{"issue":"7297","key":"31905_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09002","volume":"465","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297), 483\u2013486 (2010).","journal-title":"Nature"},{"issue":"13","key":"31905_CR25","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1084\/jem.20110398","volume":"208","author":"DA Ridder","year":"2011","unstructured":"Ridder, D. A. et al. TAK1 in brain endothelial cells mediates fever and lethargy. J. Exp. Med. 208(13), 2615\u20132623 (2011).","journal-title":"J. Exp. Med."},{"key":"31905_CR26","doi-asserted-by":"crossref","unstructured":"Westerfield, M., Doerry, E., Kirkpatrick, A.E., Driever, W., & Douglas, S.A. An On-Line Database for Zebrafish Development and Genetics Research (1997).","DOI":"10.1006\/scdb.1997.0173"},{"key":"31905_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1242\/dev.123.1.293","volume":"123","author":"JN Chen","year":"1996","unstructured":"Chen, J. N. et al. Mutations affecting the cardiovascular system and other internal organs in zebrafish. Development 123, 293\u2013302 (1996).","journal-title":"Development"},{"issue":"16","key":"31905_CR28","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1242\/dev.02469","volume":"133","author":"JD Mably","year":"2006","unstructured":"Mably, J. D. et al. Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133(16), 3139\u20133146 (2006).","journal-title":"Development"},{"issue":"23","key":"31905_CR29","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1242\/dev.02087","volume":"132","author":"SW Jin","year":"2005","unstructured":"Jin, S. W., Beis, D., Mitchell, T., Chen, J. N. & Stainier, D. Y. R. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132(23), 5199\u20135209 (2005).","journal-title":"Development"},{"issue":"7","key":"31905_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9(7), 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"issue":"3","key":"31905_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0168-9525(94)90220-8","volume":"10","author":"T Jowett","year":"1994","unstructured":"Jowett, T. & Lettice, L. A. Whole-mount in situ hybridizations on zebra- fish embryos using a mixture of digoxigenin- and fluorescein-labelled probes. Trends Genet. 10(3), 73\u201374 (1994).","journal-title":"Trends Genet."},{"issue":"8","key":"31905_CR32","first-page":"10","volume":"3","author":"C Moens","year":"2008","unstructured":"Moens, C. Whole mount RNA in situ hybridization on zebrafish embryos: Mounting. Cold Spring Harb. Protoc. 3(8), 10\u201313 (2008).","journal-title":"Cold Spring Harb. Protoc."},{"issue":"5","key":"31905_CR33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/bioinformatics\/btw676","volume":"33","author":"F Gwinner","year":"2017","unstructured":"Gwinner, F. et al. Network-based analysis of omics data: The LEAN method. Bioinformatics 33(5), 701\u2013709 (2017).","journal-title":"Bioinformatics"},{"key":"31905_CR34","unstructured":"Renz, M., Otten, C., Faurobert, E., Rudolph, F., Zhu, Y., Duchene, J., Mickoleit, M., Dietrich, A., Steed, E., Manet-dup\u00e9, S., Benz, A., & Hassel, D. Regulation of \u03b21 Integrin\u2014Klf2\u2014Mediated Angiogenesis by CCM Proteins. Supplemental Data."},{"issue":"4","key":"31905_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10456-021-09809-2","volume":"24","author":"DR Vannier","year":"2021","unstructured":"Vannier, D. R. et al. CCM2-deficient endothelial cells undergo a ROCK-dependent reprogramming into senescence-associated secretory phenotype. Angiogenesis 24(4), 843\u2013860 (2021).","journal-title":"Angiogenesis"},{"issue":"7","key":"31905_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg2340","volume":"9","author":"K Niederreither","year":"2008","unstructured":"Niederreither, K. & Doll\u00e9, P. Retinoic acid in development: Towards an integrated view. Nat. Rev. Genet. 9(7), 541\u2013553 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"31905_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1126\/science.1101573","volume":"307","author":"BR Keegan","year":"2005","unstructured":"Keegan, B. R., Feldman, J. L., Begemann, G., Ingham, P. W. & Yelon, D. Retinoic acid signaling restricts the cardiac progenitor pool. Science 307, 247\u2013249 (2005).","journal-title":"Science"},{"issue":"6","key":"31905_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.devcel.2008.09.009","volume":"15","author":"JS Waxman","year":"2008","unstructured":"Waxman, J. S., Keegan, B. R., Roberts, R. W., Poss, K. D. & Yelon, D. Hoxb5b acts downstream of retinoic acid signaling in the forelimb field to restrict heart field potential in zebrafish. Dev. Cell 15(6), 923\u2013934 (2008).","journal-title":"Dev. Cell"},{"issue":"2","key":"31905_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/STROKEAHA.111.625467","volume":"43","author":"DA McDonald","year":"2012","unstructured":"McDonald, D. A. et al. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke 43(2), 571\u2013574 (2012).","journal-title":"Stroke"},{"issue":"10","key":"31905_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0140370","volume":"10","author":"CC Gibson","year":"2015","unstructured":"Gibson, C. C. et al. Dietary vitamin D and its metabolites non-genomically stabilize the endothelium. PLoS ONE 10(10), 1\u201315 (2015).","journal-title":"PLoS ONE"},{"issue":"21","key":"31905_CR41","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1073\/pnas.1702942114","volume":"114","author":"S Nishimura","year":"2017","unstructured":"Nishimura, S. et al. Combined HMG-COA reductase and prenylation inhibition in treatment of CCM. Proc. Natl. Acad. Sci. USA 114(21), 5503\u20135508 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"31905_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.aau0731","volume":"4","author":"JP Choi","year":"2018","unstructured":"Choi, J. P. et al. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. Sci. Adv. 4(11), 1\u201312 (2018).","journal-title":"Sci. Adv."},{"issue":"7654","key":"31905_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature22075","volume":"545","author":"AT Tang","year":"2017","unstructured":"Tang, A. T. et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 545(7654), 305\u2013310 (2017).","journal-title":"Nature"},{"issue":"11","key":"31905_CR44","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1084\/jem.20171178","volume":"214","author":"MA Lopez-Ramirez","year":"2017","unstructured":"Lopez-Ramirez, M. A. et al. Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. J. Exp. Med. 214(11), 3331\u20133346 (2017).","journal-title":"J. Exp. Med."},{"issue":"3","key":"31905_CR45","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/STROKEAHA.118.024058","volume":"50","author":"R Shenkar","year":"2019","unstructured":"Shenkar, R. et al. Rho kinase inhibition blunts lesion development and hemorrhage in murine models of aggressive Pdcd10\/Ccm3 disease. Stroke 50(3), 738\u2013744 (2019).","journal-title":"Stroke"},{"issue":"6","key":"31905_CR46","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00429-015-1102-z","volume":"221","author":"PN Stoney","year":"2016","unstructured":"Stoney, P. N. et al. Expression of the retinoic acid catabolic enzyme CYP26B1 in the human brain to maintain signaling homeostasis. Brain Struct. Funct. 221(6), 3315\u20133326 (2016).","journal-title":"Brain Struct. Funct."},{"issue":"2","key":"31905_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.devcel.2014.12.009","volume":"32","author":"Z Zhou","year":"2015","unstructured":"Zhou, Z. et al. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression. Dev. Cell 32(2), 168\u2013180 (2015).","journal-title":"Dev. Cell"},{"key":"31905_CR48","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fncel.2018.00476","volume":"12","author":"S Bonney","year":"2018","unstructured":"Bonney, S., Dennison, B. J. C., Wendlandt, M. & Siegenthaler, J. A. Retinoic acid regulates endothelial \u03b2-catenin expression and pericyte numbers in the developing brain vasculature. Front. Cell. Neurosci. 12, 476 (2018).","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"31905_CR49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00401-014-1335-6","volume":"128","author":"MR Mizee","year":"2014","unstructured":"Mizee, M. R. et al. Astrocyte-derived retinoic acid: A novel regulator of blood\u2013brain barrier function in multiple sclerosis. Acta Neuropathol. 128(5), 691\u2013703 (2014).","journal-title":"Acta Neuropathol."},{"issue":"12","key":"31905_CR50","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1073\/pnas.1231422100","volume":"100","author":"FA Mic","year":"2003","unstructured":"Mic, F. A., Molotkov, A., Benbrook, D. M. & Duester, G. Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc. Natl. Acad. Sci. USA 100(12), 7135\u20137140 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"31905_CR51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.devcel.2018.10.017","volume":"47","author":"S Anbalagan","year":"2018","unstructured":"Anbalagan, S. et al. Pituicyte cues regulate the development of permeable neuro-vascular interfaces. Dev. Cell 47(6), 711-726.e5 (2018).","journal-title":"Dev. Cell"},{"key":"31905_CR52","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biocel.2016.09.011","volume":"81","author":"SF Retta","year":"2016","unstructured":"Retta, S. F. & Glading, A. J. Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin. Int. J. Biochem. Cell Biol. 81, 254\u2013270 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"31905_CR53","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.1038\/s41598-017-08373-4","volume":"7","author":"L Goitre","year":"2017","unstructured":"Goitre, L. et al. Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium. Sci. Rep. 7(1), 8296 (2017).","journal-title":"Sci. Rep."},{"key":"31905_CR54","doi-asserted-by":"crossref","unstructured":"Perrelli, A., Ferraris, C., Berni, E., Glading, A.J., & Retta, S.F. KRIT1: A traffic warden at the busy crossroads between redox signaling and the pathogenesis of cerebral cavernous malformation disease. Antioxid. Redox Signal. (2022).","DOI":"10.1089\/ars.2021.0263"},{"key":"31905_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109527","volume":"68","author":"F Finetti","year":"2020","unstructured":"Finetti, F. et al. KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses. Cell. Signal. 68, 109527 (2020).","journal-title":"Cell. Signal."},{"issue":"1","key":"31905_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0925-4773(96)00653-3","volume":"62","author":"K Niederreither","year":"1997","unstructured":"Niederreither, K., McCaffery, P., Dr\u00e4ger, U. C., Chambon, P. & Doll\u00e9, P. Restricted expression and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse development. Mech. Dev. 62(1), 67\u201378 (1997).","journal-title":"Mech. Dev."},{"issue":"19","key":"31905_CR57","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.3390\/cancers13194972","volume":"13","author":"S Kumar","year":"2021","unstructured":"Kumar, S., Freelander, A. & Lim, E. Type 1 nuclear receptor activity in breast cancer: Translating preclinical insights to the clinic. Cancers 13(19), 4972 (2021).","journal-title":"Cancers"},{"issue":"1","key":"31905_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1210\/er.2012-1012","volume":"34","author":"CM Girgis","year":"2013","unstructured":"Girgis, C. M., Clifton-Bligh, R. J., Hamrick, M. W., Holick, M. F. & Gunton, J. E. The roles of vitamin D in skeletal muscle: Form, function, and metabolism. Endocr. Rev. 34(1), 33\u201383 (2013).","journal-title":"Endocr. Rev."},{"issue":"1","key":"31905_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/er.2003-0023","volume":"25","author":"CL Smith","year":"2004","unstructured":"Smith, C. L. & O\u2019Malley, B. W. Coregulator function: A key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25(1), 45\u201371 (2004).","journal-title":"Endocr. Rev."},{"key":"31905_CR60","unstructured":"Zhang, J., & Abou-Fadel, J.S. Calm the Raging Hormone\u2014A New Therapeutic Strategy Involving Progesterone-Signaling for Hemorrhagic CCMs HHS Public Access."},{"issue":"17","key":"31905_CR61","doi-asserted-by":"publisher","first-page":"9684","DOI":"10.3390\/ijms23179684","volume":"23","author":"J Abou-Fadel","year":"2022","unstructured":"Abou-Fadel, J. et al. mPR-specific actions influence maintenance of the blood\u2013brain barrier (BBB). Int. J. Mol. Sci. 23(17), 9684 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"44","key":"31905_CR62","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1038\/onc.2017.204","volume":"36","author":"LM Fettig","year":"2017","unstructured":"Fettig, L. M. et al. Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells. Oncogene 36(44), 6074\u20136084 (2017).","journal-title":"Oncogene"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31905-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31905-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31905-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T11:04:50Z","timestamp":1680692690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31905-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31905"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31905-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5572"}}